Plasma sE-selection in premature infants: A possible surrogate marker of retinopathy of prematurity

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 7, 2010, Pages 3709-3713

  Pieh, Christina ^a,b   Krüger, Marcus ^b,c   Lagreze, Wolf Alexander ^a   Gimpel, Charlotte ^c   Buschbeck, Christiane ^a   Zirrgiebel, Ute ^c   Agostini, Hansjürgen T ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c PROQINASE GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; SOLUBLE E SELECTIN; SURFACTANT; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; SELE PROTEIN, HUMAN;

ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; DRUG USE; GESTATIONAL AGE; HUMAN; INFANT; LOW BIRTH WEIGHT; MOLECULAR PATHOLOGY; PREMATURITY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RETROLENTAL FIBROPLASIA; RISK FACTOR; BIRTH WEIGHT; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; NEWBORN; RECEIVER OPERATING CHARACTERISTIC;

BIOLOGICAL MARKERS; BIRTH WEIGHT; E-SELECTIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; PROSPECTIVE STUDIES; RETINOPATHY OF PREMATURITY; RISK FACTORS; ROC CURVE;

EID: 77955898904     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-4723     Document Type: Article

References (33)

1. Steinkuller PG, Du L, Gilbert C, et al. Childhood blindness. J AAPOS. 1999;3(1):26-32.
2. Riise R, Flage T, Hansen E, et al. Visual impairment due to retinopathy of prematurity in Nordic children. Acta Ophthalmol Suppl. 1993(210):9-11.
3. Pieh C, Agostini H, Buschbeck C, et al. VEGF-A, VEGFR-1, VEGFR-2 and Tie2 levels in plasma of premature infants: relationship to retinopathy of prematurity. Br J Ophthalmol. 2008;92(5): 689-693.
4. Sarlos S, Rizkalla B, Moravski CJ, et al. Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin. Am J Pathol. 2003;163(3):879-887.
5. Umeda N, Ozaki H, Hayashi H, et al. Colocalization of Tie2, angiopoietin 2 and vascular endothelial growth factor in fibrovascular membrane from patients with retinopathy of prematurity. Ophthalmic Res. 2003;35(4):217-223.
6. Stone J, Chan-Ling T, Pe'er J, et al. Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity. Invest Ophthalmol Vis Sci. 1996;37(2): 290-299.
7. Lashkari K, Hirose T, Yazdany J, et al. Vascular endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity. Am J Pathol. 2000;156(4):1337-1344.
8. Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol. 2007;7(9):678-689.
9. Nguyen M, Strubel NA, Bischoff J. A role for sialyl Lewis-X/A glycoconjugates in capillary morphogenesis. Nature. 1993; 365(6443):267-269.
10. Koch AE, Halloran MM, Haskell CJ, et al. Angiogenesis mediated by soluble forms of E-selection and vascular cell adhesion molecule-1. Nature. 1995;376(6540):517-519.
11. Koch AE. Angiogenesis as a target in rheumatoid arthritis. Ann Rheum Dis. 2003;62(suppl 2): ii60-ii67.
12. Pigott R, Dillon LP, Hemingway IH, Gearing AJ. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun. 1992;187(2):584-589.
13. Giannaki G, Rizos D, Xyni K, et al. Serum soluble E- and L-selection in the very early neonatal period. Early Hum Dev. 2000;60(2): 149-155.
14. Austgulen R, Arntzen KJ, Haereid PE, et al. Infections in neonates delivered at term are associated with increased serum levels of ICAM-1 and E-selection. Acta Paediatr. 1997;86(3):274-280.
15. Ballabh P, Kumari J, Krauss AN, et al. Soluble E-selection, soluble L-selection and soluble ICAM-1 in bronchopulmonary dysplasia, and changes with dexamethasone. Pediatrics. 2003;111(3):461-468.
16. Hebbar M, Peyrat JP. Significance of soluble endothelial molecule E-selection in patients with breast cancer. Int J Biol Markers. 2000;15(1):15-21.
17. Benekli M, Gullu IH, Tekuzman G, et al. Circulating intercellular adhesion molecule-1 and E-selection levels in gastric cancer. Br J Cancer. 1998;78(2):267-271.
18. Limb GA, Hickman-Casey J, Hollifield RD, Chignell AH. Vascular adhesion molecules in vitreous from eyes with proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 1999;40(10): 2453-2457.
19. Knudsen ST, Foss CH, Poulsen PL, et al. E-selection-inducing activity in plasma from type 2 diabetic patients with maculopathy. Am J Physiol Endocrinol Metab. 2003;284(1):E1-E6.
20. Akkoyun I, Oto S, Yilmaz G, et al. Risk factors in the development of mild and severe retinopathy of prematurity. J AAPOS. 2006; 10(5):449-453.
21. Lad EM, Nguyen TC, Morton JM, Moshfeghi DM. Retinopathy of prematurity in the United States. Br J Ophthalmol. 2008;92(3): 320-325.
22. Mutlu FM, Altinsoy HI, Mumcuoglu T, et al. Screening for retinop-athy of prematurity in a tertiary care newborn unit in Turkey: frequency, outcomes, and risk factor analysis. J Pediatr Ophthal-mol Strabismus. 2008;45(5):291-298.
23. Betensky RA. Local estimation of smooth curves for longitudinal data. Stat Med. 1997;16(21):2429-2445.
24. Bancalari E, Claure N, Sosenko IR. Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition. Semin Neo-natol. 2003;8(1):63-71.
25. Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol. 1988;106(4):471-479.
26. Ramsay PL, O'Brian Smith E, Hegemier S, Welty SE. Early clinical markers for the development of bronchopulmonary dysplasia: soluble E-selection and ICAM-1. Pediatrics. 1998;102:927-932.
27. Kumar P, Amin MA, Harlow LA, et al. Src and phosphatidylinositol 3-kinase mediate soluble E-selection-induced angiogenesis. Blood. 2003;101(10):3960-3968.
28. Jiang BH, Zheng JZ, Aoki M, Vogt PK. Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endo-thelial growth factor in endothelial cells. Proc Natl Acad Sci U S A. 2000;97(4):1749-1753.
29. Siemianowicz K, Francuz T, Gminski J, et al. Endothelium dysfunction markers in patients with diabetic retinopathy. Int J Mol Med. 2005;15(3):459-462.
30. Sheen-Chen SM, Eng HL, Huang CC, Chen WJ. Serum levels of soluble E-selection in women with breast cancer. Br J Surg. 2004; 91(12):1578-1581.
31. Hebbar M, Revillion F, Louchez MM, et al. The relationship between concentrations of circulating soluble E-selection and clinical, pathological, and biological features in patients with breast cancer. Clin Cancer Res. 1998;4(2):373-380.
32. Kretzer FL, Hittner HM. Retinopathy of prematurity: clinical implications of retinal development. Arch Dis Child. 1988;63:1151-1167.
33. Kim BI, Lee HE, Choi CW, et al. Increase in cord blood soluble E-selection and tracheal aspirate neutrophils at birth and the development of new bronchopulmonary dysplasia. J Perinat Med. 2004; 32(3):282-287.